GBT

Global Blood Therapeutics, Inc.

Delisted

GBT was delisted on the 4th of October, 2022.

190 hedge funds and large institutions have $2.25B invested in Global Blood Therapeutics, Inc. in 2021 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 81 increasing their positions, 56 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
190
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$59.8M
Puts
$11.2M
Net Calls
Net Calls Change

Top Buyers

1 +$55.3M
2 +$25.8M
3 +$15.7M
4
CC
Casdin Capital
New York
+$14.4M
5
Morgan Stanley
Morgan Stanley
New York
+$13.1M

Top Sellers

1 -$51.3M
2 -$48.4M
3 -$44.7M
4
PA
Perceptive Advisors
New York
-$31.7M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$24.2M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$216M
2
$215M
3
$205M
4
$202M
5
$145M
6
$132M
7
$113M
8
$80.6M
9
$79M
10
$72.2M
11
$51M
12
$50.6M
13
$50.2M
14
$45.9M
15
$44.7M
16
$42.5M
17
$40.4M
18
$38.6M
19
$23.3M
20
$22.2M
21
$20.6M
22
$19.3M
23
$14.9M
24
$14.4M
25
$14M